Literature DB >> 18558717

The NMR structure and dynamics of the two-domain tick carboxypeptidase inhibitor reveal flexibility in its free form and stiffness upon binding to human carboxypeptidase B.

David Pantoja-Uceda1, Joan L Arolas, Pascal García, Eva López-Hernández, Daniel Padró, Francesc X Aviles, Francisco J Blanco.   

Abstract

The structure of the tick carboxypeptidase inhibitor (TCI) and its backbone dynamics, free and in complex with human carboxypeptidase B, have been determined by NMR spectroscopy. Although free TCI has the same overall fold as that observed in the crystal structures of its complexes with metallocarboxypeptidase types A and B, there are structural differences at the linker between the two domains. The linker residues have greater flexibility than the globular domains, and the C-terminal residues are highly flexible in free TCI. Upon formation of a complex with carboxypeptidase B, TCI becomes more rigid, especially at the level of the linker and at the C-terminus, which is inserted into the active site groove of the carboxypeptidase. Solvent exchange rates of the backbone amide protons also show a strong reduction of the local TCI dynamics and a stabilization of its structure upon complex formation. The findings are consistent with a recognition mechanism that primarily involves the C-terminal domain, which adjusts its conformation and that of the linker, thus facilitating complex stabilization by further interactions between the N-terminal domain and an exosite of the carboxypeptidase. This adaptability enables TCI to tune its global conformation for proper interaction with distinct types of carboxypeptidases by a mechanism of induced fit. Our results provide new information about the structure-function relationship and stability of a molecule with potential biomedical applications in thrombolytic therapy. Furthermore, the plasticity of TCI makes it an ideal scaffold for developing stronger and/or more specific inhibitors directed toward modulating the activity of metallocarboxypeptidases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558717     DOI: 10.1021/bi800403m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Structure, function, and evolution of Gga-AvBD11, the archetype of the structural avian-double-β-defensin family.

Authors:  Nicolas Guyot; Hervé Meudal; Sascha Trapp; Sophie Iochmann; Anne Silvestre; Guillaume Jousset; Valérie Labas; Pascale Reverdiau; Karine Loth; Virginie Hervé; Vincent Aucagne; Agnès F Delmas; Sophie Rehault-Godbert; Céline Landon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

2.  Catalytic residues in hydrolases: analysis of methods designed for ligand-binding site prediction.

Authors:  Katarzyna Prymula; Tomasz Jadczyk; Irena Roterman
Journal:  J Comput Aided Mol Des       Date:  2010-11-21       Impact factor: 3.686

3.  Reduced stability and increased dynamics in the human proliferating cell nuclear antigen (PCNA) relative to the yeast homolog.

Authors:  Alfredo De Biasio; Ricardo Sánchez; Jesús Prieto; Maider Villate; Ramón Campos-Olivas; Francisco J Blanco
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

4.  Pre- and post-docking sampling of conformational changes using ClustENM and HADDOCK for protein-protein and protein-DNA systems.

Authors:  Zeynep Kurkcuoglu; Alexandre M J J Bonvin
Journal:  Proteins       Date:  2019-09-03

5.  Proliferating cell nuclear antigen (PCNA) interactions in solution studied by NMR.

Authors:  Alfredo De Biasio; Ramón Campos-Olivas; Ricardo Sánchez; Jorge P López-Alonso; David Pantoja-Uceda; Nekane Merino; Maider Villate; Jose M Martin-Garcia; Francisco Castillo; Irene Luque; Francisco J Blanco
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

6.  Structural Analysis of the Black-Legged Tick Saliva Protein Salp15.

Authors:  Belén Chaves-Arquero; Cecilia Persson; Nekane Merino; Julen Tomás-Cortazar; Adriana L Rojas; Juan Anguita; Francisco J Blanco
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.